Olivier Michielin

11PUBLICATIONS
120CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursBiomolecular modelling and designInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 02, 2026
Swiss-PO 2025: Advancing Cancer Mutation and Structural Analysis for Precision Oncology With the Latest Release.

Fanny S Krebs, Olivier Michielin, Vincent Zoete

|Jun 27, 2025
Engineered CD4 TCR T cells with conserved high-affinity TCRs targeting NY-ESO-1 for advanced cellular therapies in cancer.

Margaux Saillard, Mara Cenerenti, Patrick Reichenbach

|Oct 25, 2024
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment.

Douglas Hanahan, Olivier Michielin, Mikael J Pittet

|Apr 30, 2024
SwissDock 2024: major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina.

Marine Bugnon, Ute F Röhrig, Mathilde Goullieux

|Oct 18, 2023
Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial.

André Manuel da Silva Lopes, Sara Colomer-Lahiguera, Célia Darnac

|Jul 22, 2023
Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors.

André Manuel da Silva Lopes, Sara Colomer-Lahiguera, Célia Darnac

Pageof 2

Frequent Collaborators

4 joint publications

Vincent Zoete

2 joint publications

Nuria Mederos

2 joint publications

Sara Colomer-Lahiguera

2 joint publications

Michel Cuendet